The North America Nasal Cannula Market would witness market growth of 3.8% CAGR during the forecast period (2021-2027).
A nasal cannula is largely used wherever supplemental oxygen is required. It is added without rigid control of respiration as required in oxygen therapy. Oxygen flows at a lower flow rate through most of the cannula up to 5 liters per minute (L/min). They deliver oxygen to the patient’s body at a lower concentration of about 28–44%. When the rate of oxygen supply exceeds above 5 L/min, it results in discomfort to the patient. This may cause the drying of the nasal passages or nasal bleeds (epistaxis). The laminar flow becomes turbulent when flow rates reach above 6 L/min and the oxygen therapy being used is similar to deliver 5-6 L/min.
The nasal cannula is used to increase airflow and supply oxygen to the patient. Nasal cannula find their application in hospital environments, extended care, and at home. To prevent the drying of the airways, sometimes humidified air is delivered through the nasal cannula. The nasal cannula is usually specified for people who require a small percentage of oxygen supplements and for those patients who are non-critical but have low oxygen saturation levels.
The demand for laparoscopic nasal cannula is high in North America. In the United States, there are many supportive healthcare policies, while more patients suffering from respiratory problems as well as there is a developed healthcare market. According to the Centers for Disease Control and Prevention, more than 9 million adults were suffering from chronic bronchitis in 2017. Also, about 3.5 million people were diagnosed with emphysema in the United States. Therefore, the increasing patient pool and growing disposable revenue in this region boost the growth of the nasal cannula market during the forecast period. Moreover, the increasing preference for non-invasive ventilation (NIV) and rising demand for continuous positive airway pressure (CPAP) devices have in-home care settings for patients with respiratory diseases in very high in North America. To fulfil the increasing demand for the products, the key manufacturers are focused to increase the production of high-flow nasal cannula devices. It is likely to act as a driving factor for the growth of the market.
The US market dominated the North America Silicone Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $335.4 million by 2027. The Canada market is experiencing a CAGR of 7.2% during (2021-2027). Additionally, The Mexico market would witness a CAGR of 6.3% during (2021-2027).
Based on Material, the market is segmented into Plastic and Silicone. Based on End Use, the market is segmented into Hospitals, Long Term Care Centers, Ambulatory Healthcare Services, and Other End Uses. Based on Type, the market is segmented into Low Flow Nasal Cannula and High Flow Nasal Cannula. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Nasal Cannula Market is Estimated to Reach USD 7.9 Billion by 2027 at a CAGR of 4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allied Healthcare Products, Inc., Besmed Health Business Corporation, ResMed, Inc., Teleflex, Inc., Medical Depot, Inc. (Drive DeVilbiss Healthcare), Fairmont Medical Products Pty. Ltd., Fisher and Paykel Healthcare Limited, Sunset Healthcare Solutions, Inc., Smiths Group PLC, and Flexicare Medical Ltd.
By Material
By End Use
By Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
